Alzheimer's disease, Cassava
Cassava, former execs ink SEC deal to resolve allegations around misleading Alzheimer's data drop
Cassava Sciences has agreed to pay $40 million to resolve an investigation into claims it made m | Cassava Sciences has agreed to pay $40 million to resolve an investigation into claims it made misleading statements about phase 2b data on its Alzheimer’s disease drug candidate.
SEC Charges Cassava Sciences, Former Executives for Misleading Claims in Alzheimer's Trial
Cassava Sciences and two former executives will pay more than $40 million to settle charges related to misleading statements made about a clinical trial for the company's purported therapeutic treatment of Alzheimer's disease,
After nabbing a new FDA license for Rexulti in Alzheimer’s agitation last year, the drug’s marketing duo Lundbeck and Otsuka ...
Discover how exercise, a healthy diet, and socialization can help combat Alzheimer's disease. Learn more about the importance ...
Legal counsel for the 83-year-old CEO of Herring Networks seek to block his deposition in Dominion Voting's ...
A critical review of the limitations posed by current preclinical animal models of Alzheimer's disease and of the oversimplistic assumptions proposed by the amyloid cascade hypothesis (ACH).
With nearly seven million people currently living with Alzheimer's in the US, advocates stress the urgency of finding a cure, ...
Hundreds of walkers will lace up their shoes this weekend to raise money to battle Alzheimer’s and Huntington’s Disease.
New research says that light pollution and Alzheimer's may actually have a connection. Here's what you need to know.
Leptin, a hormone that helps with weight control, also plays a role in normal cognition. Leptin resistance occurs when the ...
18h
Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with ...
Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...
About 6.7 million Americans age 65 and older are living with Alzheimer's dementia, according to the NIH. By 2060, that could hit 13.8 million.
Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback